Concepedia

Azhar Rana

AR

Statistics

Publications

4

Citations

256

H-Index

4

Active since

2012

Affiliations

Novo Nordisk (Denmark)(Current)

Brod Group

University of Birmingham

Azhar Rana is an author at Novo Nordisk (Denmark) specializing in diabetes management, insulin therapy, and endocrinology.

Publications per year

2012–2014

4

Publications

4

Insulin Degludec Versus Insulin Glargine in Type 1 and Type 2 Diabetes Mellitus: A Meta-Analysis of Endpoints in Phase 3a Trials

Jiten Vora, Torsten Christensen, Azhar Rana et al. · Diabetes Therapy · 2014 · 97 citations · Full text

, , +17

Adherence patterns in patients with type 2 diabetes on basal insulin analogues: missed, mistimed and reduced doses

Meryl Brod, Azhar Rana, Anthony Barnett · Current Medical Research and Opinion · 2012 · 78 citations

, , +17

Impact of self-treated hypoglycaemia in type 2 diabetes: a multinational survey in patients and physicians

Meryl Brod, Azhar Rana, Anthony Barnett · Current Medical Research and Opinion · 2012 · 65 citations

, , +17

200 U/ml Insulin Degludec Improves Glycemic Control Similar to Insulin Glargine with a Low Risk of Hypoglycemia in Insulin-naïve People with Type 2 Diabetes

Richard M. Bergenstal, Anuj Bhargava, Rajeev Jain et al. · Canadian Journal of Diabetes · 2012 · 16 citations

, , +11

1–4 of 4